An UpToDate review on "Screening for prostate cancer" (Hoffman, 2018) recommend prostate cancer screening beginning at age 40 to 45 years for men at high risk (e.g., black men, men with family history of prostate cancer, particularly in relatives younger than age 65, and men who are know...
Prostate cancer is the most frequent new cancer diagnosis in the Western world. Prostate-specific antigen (PSA) was shown to be an adequate tool in prostate cancer screening. However, in men with a PSA level between 4.0 and 10 ng/ml its predictive value is low. PSA serum levels are ...
Is screening—an important means of cancer control for many sites—a reasonable approach for prostate cancer control? The answer is not straightforward because prostate cancer is not one, but three diseases: a latent form which will cause no harm; a progressive form which will become symptomatic ...
Prostate Cancer Screening According to the National Cancer Institute (NCI), prostate cancer is the second leading cancer killer among men. An estimated one in six men will be diagnosed with prostate cancer in his lifetime, and more than 30,000 Americans die of the disease each year. As a r...
Cancer screening: Theory and applications AnssiAuvinen,AntonBarchuk, inReference Module in Biomedical Sciences, 2024 Abstract The objective of screening is to reduce the public health burden from the target disease. For cancer, this means primarily prevention of cancer screening deaths. For some ca...
prostate cancer in their lifetime, making it the second most common cancer in men. Screening for prostate cancer typically involves a combination of adigital rectal exam (DRE)and aprostate-specific antigen (PSA) blood test. However, the use of DRE in prostate cancer surveillance has been ...
So, should all men avoid prostate cancer screening tests? No, Brawley says. "I am for informed decision-making. I will admit it may save lives, but I would like to tailor screening to men who are at higher risk and men who are very concerned about prostate cancer." ...
UK National Screening Committee (NSC). The UK NSC Recommendation on Prostate Cancer Screening/PSA Testing in Men Over the Age of 50. Accessed February 29, 2020. https://legacyscreening.phe.org.uk/prostatecancer 3. Hugosson J, Roobol MJ, Månsson M, et al; ERSPC investigators....
Prostate-Specific Antigen–Based Screening for Prostate Cancer: A Systematic Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 154. Rockville, MD: Agency for Healthcare Research and Quality; 2018. AHRQ publication 17-05229-EF-1. 4. Fenton JJ, Weyrich MS, Durbin ...
In this chapter we aim to give insight in the burden of prostate cancer and the effects of early detection and treatments using ample available data from cancer registries and (randomized) clinical trials. Prostate cancer is the leading cancer type in me